Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,024
archived clinical trials in
Infectious Disease

GSK2251052 in the Treatment of Complicated Intra-abdominal Infections
A Study to Assess the Safety, Tolerability and Preliminary Efficacy of GSK2251052 in the Treatment of Complicated Intra-abdominal Infection in Adults
Status: Enrolling
Updated:  10/23/2017
GSK Investigational Site
mi
from
Richmond, VA
GSK2251052 in the Treatment of Complicated Intra-abdominal Infections
A Study to Assess the Safety, Tolerability and Preliminary Efficacy of GSK2251052 in the Treatment of Complicated Intra-abdominal Infection in Adults
Status: Enrolling
Updated: 10/23/2017
GSK Investigational Site
mi
from
Richmond, VA
Click here to add this to my saved trials
GSK2251052 in the Treatment of Complicated Intra-abdominal Infections
A Study to Assess the Safety, Tolerability and Preliminary Efficacy of GSK2251052 in the Treatment of Complicated Intra-abdominal Infection in Adults
Status: Enrolling
Updated:  10/23/2017
GSK Investigational Site
mi
from
Chicoutimi,
GSK2251052 in the Treatment of Complicated Intra-abdominal Infections
A Study to Assess the Safety, Tolerability and Preliminary Efficacy of GSK2251052 in the Treatment of Complicated Intra-abdominal Infection in Adults
Status: Enrolling
Updated: 10/23/2017
GSK Investigational Site
mi
from
Chicoutimi,
Click here to add this to my saved trials
Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL
Phase 2a Double-Blind, Randomized, Parallel Group, Dose-Ranging Study to Assess the Safety and Efficacy of Three Doses of TVGV-1 Vaccine Compared to Its Adjuvant, GPI-0100, in Subjects With Histologically Confirmed HPV Induced Cervical HSIL
Status: Enrolling
Updated:  10/24/2017
Red Rocks OBGYN
mi
from
Lakewood, CO
Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL
Phase 2a Double-Blind, Randomized, Parallel Group, Dose-Ranging Study to Assess the Safety and Efficacy of Three Doses of TVGV-1 Vaccine Compared to Its Adjuvant, GPI-0100, in Subjects With Histologically Confirmed HPV Induced Cervical HSIL
Status: Enrolling
Updated: 10/24/2017
Red Rocks OBGYN
mi
from
Lakewood, CO
Click here to add this to my saved trials
Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL
Phase 2a Double-Blind, Randomized, Parallel Group, Dose-Ranging Study to Assess the Safety and Efficacy of Three Doses of TVGV-1 Vaccine Compared to Its Adjuvant, GPI-0100, in Subjects With Histologically Confirmed HPV Induced Cervical HSIL
Status: Enrolling
Updated:  10/24/2017
Progressive Medical Research
mi
from
Port Orange, FL
Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL
Phase 2a Double-Blind, Randomized, Parallel Group, Dose-Ranging Study to Assess the Safety and Efficacy of Three Doses of TVGV-1 Vaccine Compared to Its Adjuvant, GPI-0100, in Subjects With Histologically Confirmed HPV Induced Cervical HSIL
Status: Enrolling
Updated: 10/24/2017
Progressive Medical Research
mi
from
Port Orange, FL
Click here to add this to my saved trials
Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL
Phase 2a Double-Blind, Randomized, Parallel Group, Dose-Ranging Study to Assess the Safety and Efficacy of Three Doses of TVGV-1 Vaccine Compared to Its Adjuvant, GPI-0100, in Subjects With Histologically Confirmed HPV Induced Cervical HSIL
Status: Enrolling
Updated:  10/24/2017
Comprehensive Clinical Trials
mi
from
West Palm Beach, FL
Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL
Phase 2a Double-Blind, Randomized, Parallel Group, Dose-Ranging Study to Assess the Safety and Efficacy of Three Doses of TVGV-1 Vaccine Compared to Its Adjuvant, GPI-0100, in Subjects With Histologically Confirmed HPV Induced Cervical HSIL
Status: Enrolling
Updated: 10/24/2017
Comprehensive Clinical Trials
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL
Phase 2a Double-Blind, Randomized, Parallel Group, Dose-Ranging Study to Assess the Safety and Efficacy of Three Doses of TVGV-1 Vaccine Compared to Its Adjuvant, GPI-0100, in Subjects With Histologically Confirmed HPV Induced Cervical HSIL
Status: Enrolling
Updated:  10/24/2017
Grady Memorial Hospital
mi
from
Atlanta, GA
Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL
Phase 2a Double-Blind, Randomized, Parallel Group, Dose-Ranging Study to Assess the Safety and Efficacy of Three Doses of TVGV-1 Vaccine Compared to Its Adjuvant, GPI-0100, in Subjects With Histologically Confirmed HPV Induced Cervical HSIL
Status: Enrolling
Updated: 10/24/2017
Grady Memorial Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL
Phase 2a Double-Blind, Randomized, Parallel Group, Dose-Ranging Study to Assess the Safety and Efficacy of Three Doses of TVGV-1 Vaccine Compared to Its Adjuvant, GPI-0100, in Subjects With Histologically Confirmed HPV Induced Cervical HSIL
Status: Enrolling
Updated:  10/24/2017
ProHEALTH Care Associates LLP
mi
from
Port Jefferson, NY
Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL
Phase 2a Double-Blind, Randomized, Parallel Group, Dose-Ranging Study to Assess the Safety and Efficacy of Three Doses of TVGV-1 Vaccine Compared to Its Adjuvant, GPI-0100, in Subjects With Histologically Confirmed HPV Induced Cervical HSIL
Status: Enrolling
Updated: 10/24/2017
ProHEALTH Care Associates LLP
mi
from
Port Jefferson, NY
Click here to add this to my saved trials
Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL
Phase 2a Double-Blind, Randomized, Parallel Group, Dose-Ranging Study to Assess the Safety and Efficacy of Three Doses of TVGV-1 Vaccine Compared to Its Adjuvant, GPI-0100, in Subjects With Histologically Confirmed HPV Induced Cervical HSIL
Status: Enrolling
Updated:  10/24/2017
Unified Women's Clinical Research
mi
from
Raleigh, NC
Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL
Phase 2a Double-Blind, Randomized, Parallel Group, Dose-Ranging Study to Assess the Safety and Efficacy of Three Doses of TVGV-1 Vaccine Compared to Its Adjuvant, GPI-0100, in Subjects With Histologically Confirmed HPV Induced Cervical HSIL
Status: Enrolling
Updated: 10/24/2017
Unified Women's Clinical Research
mi
from
Raleigh, NC
Click here to add this to my saved trials
Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL
Phase 2a Double-Blind, Randomized, Parallel Group, Dose-Ranging Study to Assess the Safety and Efficacy of Three Doses of TVGV-1 Vaccine Compared to Its Adjuvant, GPI-0100, in Subjects With Histologically Confirmed HPV Induced Cervical HSIL
Status: Enrolling
Updated:  10/24/2017
Unified Women's Clinical Research
mi
from
Winston-Salem, NC
Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL
Phase 2a Double-Blind, Randomized, Parallel Group, Dose-Ranging Study to Assess the Safety and Efficacy of Three Doses of TVGV-1 Vaccine Compared to Its Adjuvant, GPI-0100, in Subjects With Histologically Confirmed HPV Induced Cervical HSIL
Status: Enrolling
Updated: 10/24/2017
Unified Women's Clinical Research
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL
Phase 2a Double-Blind, Randomized, Parallel Group, Dose-Ranging Study to Assess the Safety and Efficacy of Three Doses of TVGV-1 Vaccine Compared to Its Adjuvant, GPI-0100, in Subjects With Histologically Confirmed HPV Induced Cervical HSIL
Status: Enrolling
Updated:  10/24/2017
Insearch-Tidewater Clinical Research
mi
from
Norfolk, VA
Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL
Phase 2a Double-Blind, Randomized, Parallel Group, Dose-Ranging Study to Assess the Safety and Efficacy of Three Doses of TVGV-1 Vaccine Compared to Its Adjuvant, GPI-0100, in Subjects With Histologically Confirmed HPV Induced Cervical HSIL
Status: Enrolling
Updated: 10/24/2017
Insearch-Tidewater Clinical Research
mi
from
Norfolk, VA
Click here to add this to my saved trials
Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL
Phase 2a Double-Blind, Randomized, Parallel Group, Dose-Ranging Study to Assess the Safety and Efficacy of Three Doses of TVGV-1 Vaccine Compared to Its Adjuvant, GPI-0100, in Subjects With Histologically Confirmed HPV Induced Cervical HSIL
Status: Enrolling
Updated:  10/24/2017
Visions Clinical Research - Tucson
mi
from
Tucson, AZ
Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL
Phase 2a Double-Blind, Randomized, Parallel Group, Dose-Ranging Study to Assess the Safety and Efficacy of Three Doses of TVGV-1 Vaccine Compared to Its Adjuvant, GPI-0100, in Subjects With Histologically Confirmed HPV Induced Cervical HSIL
Status: Enrolling
Updated: 10/24/2017
Visions Clinical Research - Tucson
mi
from
Tucson, AZ
Click here to add this to my saved trials
Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL
Phase 2a Double-Blind, Randomized, Parallel Group, Dose-Ranging Study to Assess the Safety and Efficacy of Three Doses of TVGV-1 Vaccine Compared to Its Adjuvant, GPI-0100, in Subjects With Histologically Confirmed HPV Induced Cervical HSIL
Status: Enrolling
Updated:  10/24/2017
Complete Healthcare for Women
mi
from
Columbus, OH
Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL
Phase 2a Double-Blind, Randomized, Parallel Group, Dose-Ranging Study to Assess the Safety and Efficacy of Three Doses of TVGV-1 Vaccine Compared to Its Adjuvant, GPI-0100, in Subjects With Histologically Confirmed HPV Induced Cervical HSIL
Status: Enrolling
Updated: 10/24/2017
Complete Healthcare for Women
mi
from
Columbus, OH
Click here to add this to my saved trials
Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL
Phase 2a Double-Blind, Randomized, Parallel Group, Dose-Ranging Study to Assess the Safety and Efficacy of Three Doses of TVGV-1 Vaccine Compared to Its Adjuvant, GPI-0100, in Subjects With Histologically Confirmed HPV Induced Cervical HSIL
Status: Enrolling
Updated:  10/24/2017
Penn Fertility Care/Reproductive Research Unit Univ of Pennsylvania
mi
from
Philadelphia, PA
Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL
Phase 2a Double-Blind, Randomized, Parallel Group, Dose-Ranging Study to Assess the Safety and Efficacy of Three Doses of TVGV-1 Vaccine Compared to Its Adjuvant, GPI-0100, in Subjects With Histologically Confirmed HPV Induced Cervical HSIL
Status: Enrolling
Updated: 10/24/2017
Penn Fertility Care/Reproductive Research Unit Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Repeat Sexually Transmitted Infection (STI) Patients: Tailored Socio-Contextual Intervention to Reduce HIV Risk
Repeat STI Patients: Tailored Socio-Contextual Intervention to Reduce HIV Risk
Status: Enrolling
Updated:  10/25/2017
University of Wisconsin Milwaukee - Zilber School of Public Health
mi
from
Milwaukee, WI
Repeat Sexually Transmitted Infection (STI) Patients: Tailored Socio-Contextual Intervention to Reduce HIV Risk
Repeat STI Patients: Tailored Socio-Contextual Intervention to Reduce HIV Risk
Status: Enrolling
Updated: 10/25/2017
University of Wisconsin Milwaukee - Zilber School of Public Health
mi
from
Milwaukee, WI
Click here to add this to my saved trials
GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection
A Randomized, Double Blind, Double Dummy Multicenter Phase IIa Study to Assess Safety, Tolerability and Efficacy of GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection
Status: Enrolling
Updated:  10/25/2017
GSK Investigational Site
mi
from
Anniston, AL
GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection
A Randomized, Double Blind, Double Dummy Multicenter Phase IIa Study to Assess Safety, Tolerability and Efficacy of GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection
Status: Enrolling
Updated: 10/25/2017
GSK Investigational Site
mi
from
Anniston, AL
Click here to add this to my saved trials
GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection
A Randomized, Double Blind, Double Dummy Multicenter Phase IIa Study to Assess Safety, Tolerability and Efficacy of GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection
Status: Enrolling
Updated:  10/25/2017
GSK Investigational Site
mi
from
Chula Vista, CA
GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection
A Randomized, Double Blind, Double Dummy Multicenter Phase IIa Study to Assess Safety, Tolerability and Efficacy of GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection
Status: Enrolling
Updated: 10/25/2017
GSK Investigational Site
mi
from
Chula Vista, CA
Click here to add this to my saved trials
GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection
A Randomized, Double Blind, Double Dummy Multicenter Phase IIa Study to Assess Safety, Tolerability and Efficacy of GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection
Status: Enrolling
Updated:  10/25/2017
GSK Investigational Site
mi
from
La Mesa, CA
GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection
A Randomized, Double Blind, Double Dummy Multicenter Phase IIa Study to Assess Safety, Tolerability and Efficacy of GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection
Status: Enrolling
Updated: 10/25/2017
GSK Investigational Site
mi
from
La Mesa, CA
Click here to add this to my saved trials
GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection
A Randomized, Double Blind, Double Dummy Multicenter Phase IIa Study to Assess Safety, Tolerability and Efficacy of GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection
Status: Enrolling
Updated:  10/25/2017
GSK Investigational Site
mi
from
Long Beach, CA
GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection
A Randomized, Double Blind, Double Dummy Multicenter Phase IIa Study to Assess Safety, Tolerability and Efficacy of GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection
Status: Enrolling
Updated: 10/25/2017
GSK Investigational Site
mi
from
Long Beach, CA
Click here to add this to my saved trials
GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection
A Randomized, Double Blind, Double Dummy Multicenter Phase IIa Study to Assess Safety, Tolerability and Efficacy of GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection
Status: Enrolling
Updated:  10/25/2017
GSK Investigational Site
mi
from
Oceanside, CA
GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection
A Randomized, Double Blind, Double Dummy Multicenter Phase IIa Study to Assess Safety, Tolerability and Efficacy of GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection
Status: Enrolling
Updated: 10/25/2017
GSK Investigational Site
mi
from
Oceanside, CA
Click here to add this to my saved trials
GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection
A Randomized, Double Blind, Double Dummy Multicenter Phase IIa Study to Assess Safety, Tolerability and Efficacy of GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection
Status: Enrolling
Updated:  10/25/2017
GSK Investigational Site
mi
from
Honolulu, HI
GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection
A Randomized, Double Blind, Double Dummy Multicenter Phase IIa Study to Assess Safety, Tolerability and Efficacy of GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection
Status: Enrolling
Updated: 10/25/2017
GSK Investigational Site
mi
from
Honolulu, HI
Click here to add this to my saved trials
GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection
A Randomized, Double Blind, Double Dummy Multicenter Phase IIa Study to Assess Safety, Tolerability and Efficacy of GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection
Status: Enrolling
Updated:  10/25/2017
GSK Investigational Site
mi
from
West Reading, PA
GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection
A Randomized, Double Blind, Double Dummy Multicenter Phase IIa Study to Assess Safety, Tolerability and Efficacy of GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection
Status: Enrolling
Updated: 10/25/2017
GSK Investigational Site
mi
from
West Reading, PA
Click here to add this to my saved trials
Screening Protocol for Subjects Being Evaluated for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Protocols
Screening Protocol for Subjects Being Evaluated for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Protocols
Status: Enrolling
Updated:  10/26/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Screening Protocol for Subjects Being Evaluated for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Protocols
Screening Protocol for Subjects Being Evaluated for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Protocols
Status: Enrolling
Updated: 10/26/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
SEP-SEQ Trial - Determining the Etiology of Sepsis Using an Infectious Disease Diagnostic Sequencing Assay
SEP-SEQ Trial - Determining the Etiology of Sepsis Using an Infectious Disease Diagnostic Sequencing Assay
Status: Enrolling
Updated:  10/26/2017
Stanford University Hospital
mi
from
Stanford, CA
SEP-SEQ Trial - Determining the Etiology of Sepsis Using an Infectious Disease Diagnostic Sequencing Assay
SEP-SEQ Trial - Determining the Etiology of Sepsis Using an Infectious Disease Diagnostic Sequencing Assay
Status: Enrolling
Updated: 10/26/2017
Stanford University Hospital
mi
from
Stanford, CA
Click here to add this to my saved trials
Efficacy and Safety of Ethanol Lock Therapy for the Prevention of Central Line-associated Bloodstream Infections
Efficacy and Safety of Ethanol Lock Therapy for the Prevention of Central Line-associated Bloodstream Infections
Status: Enrolling
Updated:  10/26/2017
Stanford University
mi
from
Palo Alto, CA
Efficacy and Safety of Ethanol Lock Therapy for the Prevention of Central Line-associated Bloodstream Infections
Efficacy and Safety of Ethanol Lock Therapy for the Prevention of Central Line-associated Bloodstream Infections
Status: Enrolling
Updated: 10/26/2017
Stanford University
mi
from
Palo Alto, CA
Click here to add this to my saved trials
A Study to Test the Ability of and Safety of GSK2110183 in Treating Langerhans Cell Histiocytosis
A Phase 2a, Open Label, Multicenter Study to Assess the Efficacy and Safety of the Oral AKT Inhibitor GSK2110183 in Subjects With Langerhans Cell Histiocytosis
Status: Enrolling
Updated:  10/27/2017
Johns Hopkins Hospital
mi
from
Baltimore, MD
A Study to Test the Ability of and Safety of GSK2110183 in Treating Langerhans Cell Histiocytosis
A Phase 2a, Open Label, Multicenter Study to Assess the Efficacy and Safety of the Oral AKT Inhibitor GSK2110183 in Subjects With Langerhans Cell Histiocytosis
Status: Enrolling
Updated: 10/27/2017
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study to Test the Ability of and Safety of GSK2110183 in Treating Langerhans Cell Histiocytosis
A Phase 2a, Open Label, Multicenter Study to Assess the Efficacy and Safety of the Oral AKT Inhibitor GSK2110183 in Subjects With Langerhans Cell Histiocytosis
Status: Enrolling
Updated:  10/27/2017
Dana-Farber Cancer Institute
mi
from
Boston, MA
A Study to Test the Ability of and Safety of GSK2110183 in Treating Langerhans Cell Histiocytosis
A Phase 2a, Open Label, Multicenter Study to Assess the Efficacy and Safety of the Oral AKT Inhibitor GSK2110183 in Subjects With Langerhans Cell Histiocytosis
Status: Enrolling
Updated: 10/27/2017
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
A Study to Test the Ability of and Safety of GSK2110183 in Treating Langerhans Cell Histiocytosis
A Phase 2a, Open Label, Multicenter Study to Assess the Efficacy and Safety of the Oral AKT Inhibitor GSK2110183 in Subjects With Langerhans Cell Histiocytosis
Status: Enrolling
Updated:  10/27/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
A Study to Test the Ability of and Safety of GSK2110183 in Treating Langerhans Cell Histiocytosis
A Phase 2a, Open Label, Multicenter Study to Assess the Efficacy and Safety of the Oral AKT Inhibitor GSK2110183 in Subjects With Langerhans Cell Histiocytosis
Status: Enrolling
Updated: 10/27/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
A Study to Test the Ability of and Safety of GSK2110183 in Treating Langerhans Cell Histiocytosis
A Phase 2a, Open Label, Multicenter Study to Assess the Efficacy and Safety of the Oral AKT Inhibitor GSK2110183 in Subjects With Langerhans Cell Histiocytosis
Status: Enrolling
Updated:  10/27/2017
Staten Island University Hospital
mi
from
Staten Island, NY
A Study to Test the Ability of and Safety of GSK2110183 in Treating Langerhans Cell Histiocytosis
A Phase 2a, Open Label, Multicenter Study to Assess the Efficacy and Safety of the Oral AKT Inhibitor GSK2110183 in Subjects With Langerhans Cell Histiocytosis
Status: Enrolling
Updated: 10/27/2017
Staten Island University Hospital
mi
from
Staten Island, NY
Click here to add this to my saved trials
A Study to Test the Ability of and Safety of GSK2110183 in Treating Langerhans Cell Histiocytosis
A Phase 2a, Open Label, Multicenter Study to Assess the Efficacy and Safety of the Oral AKT Inhibitor GSK2110183 in Subjects With Langerhans Cell Histiocytosis
Status: Enrolling
Updated:  10/27/2017
Baylor College of Medicine
mi
from
Houston, TX
A Study to Test the Ability of and Safety of GSK2110183 in Treating Langerhans Cell Histiocytosis
A Phase 2a, Open Label, Multicenter Study to Assess the Efficacy and Safety of the Oral AKT Inhibitor GSK2110183 in Subjects With Langerhans Cell Histiocytosis
Status: Enrolling
Updated: 10/27/2017
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Treating H. Pylori in Parkinson's Patients With Motor Fluctuations
Helicobacter Pylori Eradication and Motor Fluctuations in Parkinson's Disease
Status: Enrolling
Updated:  10/31/2017
UCLA Neurology
mi
from
Los Angeles, CA
Treating H. Pylori in Parkinson's Patients With Motor Fluctuations
Helicobacter Pylori Eradication and Motor Fluctuations in Parkinson's Disease
Status: Enrolling
Updated: 10/31/2017
UCLA Neurology
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Docetaxel/Cisplatin/5-Fluorouracil (TPF) Human Papillomavirus (HPV) Squamous Cell Carcinoma Study
A Phase II Study of Docetaxel/Cisplatin/5-Fluorouracil (TPF) Induction Chemotherapy Followed by Concurrent Chemoradiotherapy Using a Modified Radiation Dose in Patients With Newly Diagnosed HPV Positive, Locally Advanced Squamous Cell Carcinoma of the Oropharynx
Status: Enrolling
Updated:  11/1/2017
Dana-Farber Cancer Institute
mi
from
Boston, MA
Docetaxel/Cisplatin/5-Fluorouracil (TPF) Human Papillomavirus (HPV) Squamous Cell Carcinoma Study
A Phase II Study of Docetaxel/Cisplatin/5-Fluorouracil (TPF) Induction Chemotherapy Followed by Concurrent Chemoradiotherapy Using a Modified Radiation Dose in Patients With Newly Diagnosed HPV Positive, Locally Advanced Squamous Cell Carcinoma of the Oropharynx
Status: Enrolling
Updated: 11/1/2017
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Management of Recurrent Croup
Management of Recurrent Croup: Comparison Between Inhaled Fluticasone and Oral Prednisolone
Status: Enrolling
Updated:  11/1/2017
University of Michigan
mi
from
Ann Arbor, MI
Management of Recurrent Croup
Management of Recurrent Croup: Comparison Between Inhaled Fluticasone and Oral Prednisolone
Status: Enrolling
Updated: 11/1/2017
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Risk Assessment of Long-Haul Truck Drivers
Risk Assessment of Long-Haul Truck Drivers
Status: Enrolling
Updated:  11/3/2017
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Risk Assessment of Long-Haul Truck Drivers
Risk Assessment of Long-Haul Truck Drivers
Status: Enrolling
Updated: 11/3/2017
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Reusable Versus Disposable Draping System in Breast Reconstruction Surgery
The Effect of Reusable Versus Disposable Draping on Implant Based Breast Reconstruction Infection Rates: a Prospective Randomized Study
Status: Enrolling
Updated:  11/3/2017
Wake Forest University Baptist Medical Center Plastic & Reconstructive Surgery Department
mi
from
Winston-Salem, NC
Reusable Versus Disposable Draping System in Breast Reconstruction Surgery
The Effect of Reusable Versus Disposable Draping on Implant Based Breast Reconstruction Infection Rates: a Prospective Randomized Study
Status: Enrolling
Updated: 11/3/2017
Wake Forest University Baptist Medical Center Plastic & Reconstructive Surgery Department
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload
Deferasirox Treatment and Labile Plasma Iron in Iron Overloaded Patients Who Have Undergone Allogeneic Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  11/7/2017
City of Hope
mi
from
Duarte, CA
Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload
Deferasirox Treatment and Labile Plasma Iron in Iron Overloaded Patients Who Have Undergone Allogeneic Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 11/7/2017
City of Hope
mi
from
Duarte, CA
Click here to add this to my saved trials
An Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
A Descriptive and Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
Status: Enrolling
Updated:  11/7/2017
Alabama Vaccine CRS
mi
from
Birmingham, AL
An Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
A Descriptive and Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
Status: Enrolling
Updated: 11/7/2017
Alabama Vaccine CRS
mi
from
Birmingham, AL
Click here to add this to my saved trials
An Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
A Descriptive and Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
Status: Enrolling
Updated:  11/7/2017
Bridge HIV CRS
mi
from
San Francisco, CA
An Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
A Descriptive and Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
Status: Enrolling
Updated: 11/7/2017
Bridge HIV CRS
mi
from
San Francisco, CA
Click here to add this to my saved trials
An Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
A Descriptive and Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
Status: Enrolling
Updated:  11/7/2017
Hope Clinic of the Emory Vaccine Center CRS
mi
from
Decatur, GA
An Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
A Descriptive and Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
Status: Enrolling
Updated: 11/7/2017
Hope Clinic of the Emory Vaccine Center CRS
mi
from
Decatur, GA
Click here to add this to my saved trials
An Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
A Descriptive and Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
Status: Enrolling
Updated:  11/7/2017
UIC Project WISH CRS
mi
from
Chicago, IL
An Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
A Descriptive and Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
Status: Enrolling
Updated: 11/7/2017
UIC Project WISH CRS
mi
from
Chicago, IL
Click here to add this to my saved trials
An Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
A Descriptive and Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
Status: Enrolling
Updated:  11/7/2017
Brigham and Women's Hospital Vaccine CRS (BWH VCRS)
mi
from
Boston, MA
An Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
A Descriptive and Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
Status: Enrolling
Updated: 11/7/2017
Brigham and Women's Hospital Vaccine CRS (BWH VCRS)
mi
from
Boston, MA
Click here to add this to my saved trials
An Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
A Descriptive and Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
Status: Enrolling
Updated:  11/7/2017
Fenway Health Clinical Research Site CRS
mi
from
Boston, MA
An Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
A Descriptive and Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
Status: Enrolling
Updated: 11/7/2017
Fenway Health Clinical Research Site CRS
mi
from
Boston, MA
Click here to add this to my saved trials
An Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
A Descriptive and Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
Status: Enrolling
Updated:  11/7/2017
NY Blood Ctr./Union Square CRS
mi
from
New York, NY
An Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
A Descriptive and Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
Status: Enrolling
Updated: 11/7/2017
NY Blood Ctr./Union Square CRS
mi
from
New York, NY
Click here to add this to my saved trials
An Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
A Descriptive and Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
Status: Enrolling
Updated:  11/7/2017
Columbia P&S CRS
mi
from
New York, NY
An Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
A Descriptive and Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
Status: Enrolling
Updated: 11/7/2017
Columbia P&S CRS
mi
from
New York, NY
Click here to add this to my saved trials
An Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
A Descriptive and Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
Status: Enrolling
Updated:  11/7/2017
NY Blood Ctr./Bronx CRS
mi
from
New York, NY
An Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
A Descriptive and Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
Status: Enrolling
Updated: 11/7/2017
NY Blood Ctr./Bronx CRS
mi
from
New York, NY
Click here to add this to my saved trials
An Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
A Descriptive and Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
Status: Enrolling
Updated:  11/7/2017
University of Rochester Vaccines to Prevent HIV Infection CRS
mi
from
New York, NY
An Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
A Descriptive and Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
Status: Enrolling
Updated: 11/7/2017
University of Rochester Vaccines to Prevent HIV Infection CRS
mi
from
New York, NY
Click here to add this to my saved trials
An Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
A Descriptive and Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
Status: Enrolling
Updated:  11/7/2017
Penn Prevention Crs
mi
from
Philadelphia, PA
An Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
A Descriptive and Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
Status: Enrolling
Updated: 11/7/2017
Penn Prevention Crs
mi
from
Philadelphia, PA
Click here to add this to my saved trials
An Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
A Descriptive and Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
Status: Enrolling
Updated:  11/7/2017
Vanderbilt Vaccine (VV) CRS
mi
from
Nashville, TN
An Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
A Descriptive and Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
Status: Enrolling
Updated: 11/7/2017
Vanderbilt Vaccine (VV) CRS
mi
from
Nashville, TN
Click here to add this to my saved trials
An Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
A Descriptive and Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
Status: Enrolling
Updated:  11/7/2017
Seattle Vaccine and Prevention CRS
mi
from
Seattle, WA
An Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
A Descriptive and Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
Status: Enrolling
Updated: 11/7/2017
Seattle Vaccine and Prevention CRS
mi
from
Seattle, WA
Click here to add this to my saved trials
An Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
A Descriptive and Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
Status: Enrolling
Updated:  11/7/2017
Unidad de Vacunas IDCP-COIN-DIGECITSS CRS
mi
from
Santo Domingo,
An Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
A Descriptive and Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
Status: Enrolling
Updated: 11/7/2017
Unidad de Vacunas IDCP-COIN-DIGECITSS CRS
mi
from
Santo Domingo,
Click here to add this to my saved trials
Single Dose, Weight-Based, Dose-Escalation Study With Intravenous ETI-204 in Adult Volunteers
A Randomized, Double-Blind, Placebo-Controlled, Single Dose, Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of ETI-204 in Healthy Subjects
Status: Enrolling
Updated:  11/9/2017
Quintiles, Inc.
mi
from
Overland Park, KA
Single Dose, Weight-Based, Dose-Escalation Study With Intravenous ETI-204 in Adult Volunteers
A Randomized, Double-Blind, Placebo-Controlled, Single Dose, Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of ETI-204 in Healthy Subjects
Status: Enrolling
Updated: 11/9/2017
Quintiles, Inc.
mi
from
Overland Park, KA
Click here to add this to my saved trials